Scholarlink

<p>This work explores the antibacterial and antibiofilm activities of trifluridine (TRFD) against <i>S. aureus</i>. The Minimum Inhibitory Concentrations (MIC) and Minimum Biofilm Inhibitory Concentrations (MBIC<sub>50</sub>) for TRFD were observed at 1.562&#xa0;mg L<sup>−1</sup> and 1&#xa0;mg L<sup>−1</sup> for ciprofloxacin-susceptible <i>S. aureus</i> (CSSA) and at 0.0625&#xa0;mg L<sup>−1</sup> and 0.14&#xa0;mg L<sup>−1</sup> for ciprofloxacin-resistant <i>S. aureus</i> (CRSA). Synergistic and partial synergistic antimicrobial effects of TRFD combined with ciprofloxacin (CIP) were observed against CSSA and CRSA, respectively, along with synergistic and indifferent antibiofilm effects. The TRFD + CIP significantly increased plasma membrane damage and generated ROS, affecting staphyloxanthin production, partially reducing slime production, and inhibiting the cell surface hydrophobicity and pellicle production. TRFD + CIP also reduced the carbohydrate and eDNA contents of extracellular polymeric substances. TRFD + CIP treatment decreased <i>icaR</i>, <i>fnbA</i>, and <i>clfB</i> expression and increased <i>icaA</i>, <i>efb</i>, and <i>map</i> expression. Scanning electron microscopy analysis revealed the TRFD + CIP-treated <i>S. aureus</i> biofilm and planktonic cells with deformities and debris.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Repurposing trifluridine as an anti-Staphylococcus aureus agent targeting virulence factor staphyloxanthin and attachment genes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月19日

查看全文
  • Supriti Sandhu,
  • Nidhin Poovathumkadavil Thambi,
  • Niti Singh,
  • Arjan Singh,
  • Meenu Katoch

摘要

This work explores the antibacterial and antibiofilm activities of trifluridine (TRFD) against S. aureus. The Minimum Inhibitory Concentrations (MIC) and Minimum Biofilm Inhibitory Concentrations (MBIC50) for TRFD were observed at 1.562 mg L−1 and 1 mg L−1 for ciprofloxacin-susceptible S. aureus (CSSA) and at 0.0625 mg L−1 and 0.14 mg L−1 for ciprofloxacin-resistant S. aureus (CRSA). Synergistic and partial synergistic antimicrobial effects of TRFD combined with ciprofloxacin (CIP) were observed against CSSA and CRSA, respectively, along with synergistic and indifferent antibiofilm effects. The TRFD + CIP significantly increased plasma membrane damage and generated ROS, affecting staphyloxanthin production, partially reducing slime production, and inhibiting the cell surface hydrophobicity and pellicle production. TRFD + CIP also reduced the carbohydrate and eDNA contents of extracellular polymeric substances. TRFD + CIP treatment decreased icaR, fnbA, and clfB expression and increased icaA, efb, and map expression. Scanning electron microscopy analysis revealed the TRFD + CIP-treated S. aureus biofilm and planktonic cells with deformities and debris.